Loading...
Loading...
India's cetuximab imports from FRANCE total $49.4K across 1 shipments from 1 foreign suppliers. CREAPHARM SAS leads with $49.4K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include PHARMACEUTICAL RESEARCH ASSOCIATES INDIAPRIVATE LI. This corridor reflects India's pharmaceutical import demand for cetuximab — a concentrated sourcing relationship with select suppliers from FRANCE.

CREAPHARM SAS is the leading Cetuximab supplier from FRANCE to India, with import value of $49.4K across 1 shipments. The top 5 suppliers — CREAPHARM SAS — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CREAPHARM SAS | $49.4K | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL RESEARCH ASSOCIATES INDIAPRIVATE LI | $49.4K | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Cetuximab suppliers from FRANCE to India include CREAPHARM SAS. The leading supplier is CREAPHARM SAS with import value of $49.4K USD across 1 shipments. India imported Cetuximab worth $49.4K USD from FRANCE in total across 1 shipments.
India imported Cetuximab worth $49.4K USD from FRANCE across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Cetuximab sourced from FRANCE include PHARMACEUTICAL RESEARCH ASSOCIATES INDIAPRIVATE LI. The largest buyer is PHARMACEUTICAL RESEARCH ASSOCIATES INDIAPRIVATE LI with $49.4K in imports across 1 shipments.
The total value of Cetuximab imports from FRANCE to India is $49.4K USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists